Literature DB >> 2162469

Poor prognosis infantile fibrosarcoma with pathologic features of malignant fibrous histiocytoma after local recurrence.

E Salloum1, J M Caillaud, F Flamant, J Landman, J Lemerle.   

Abstract

In a retrospective study of infants under 1 year of age treated at our institution over a 30-year period for soft tissue tumors, eight fibrosarcomas (FS) were seen, six of which were congenital. Therapy consisted of local excision (n = 3), radiotherapy (n = 1), surgery + radiotherapy (n = 1), surgery + chemotherapy (n = 1), and surgery + chemotherapy + radiotherapy (n = 2). Among these eight patients, four are alive in first complete remission (CR) with 13, 17, 23, and 27 years of follow-up. Of the remaining four patients, two had local recurrences and are still alive in CR after re-excision of the tumor, while the other two had both local and distant relapses and died. Interestingly, in the two patients who developed distant metastases, the pathologic pattern was that of malignant fibrous histiocytoma (MFH) at the time of local recurrence. To our knowledge, no similar cases of transitions between infantile FS known for its favorable outcome and MFH have been reported in this age group. The relevance of such transitions is difficult to assess. However, given the known metastatic potential of MFH, we believe that chemotherapy regimens currently used in the management of childhood soft tissue sarcomas should be used in similar cases.

Entities:  

Mesh:

Year:  1990        PMID: 2162469     DOI: 10.1002/mpo.2950180408

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Congenital infantile fibrosarcoma of scalp. Is adjuvant therapy essential ?

Authors:  Rajinder Kumar; Aman Jagdewan; M C Sharma
Journal:  Indian J Surg Oncol       Date:  2014-09-04

2.  Infantile fibrosarcoma: radiological and clinical features.

Authors:  S J Vinnicombe; C M Hall
Journal:  Skeletal Radiol       Date:  1994-07       Impact factor: 2.199

3.  Margin status and multimodal therapy in infantile fibrosarcoma.

Authors:  Jason P Sulkowski; Mehul V Raval; Marybeth Browne
Journal:  Pediatr Surg Int       Date:  2013-06-14       Impact factor: 1.827

4.  Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Authors:  Alanna J Church; Monica L Calicchio; Valentina Nardi; Alena Skalova; Andre Pinto; Deborah A Dillon; Carmen R Gomez-Fernandez; Namitha Manoj; Josh D Haimes; Joshua A Stahl; Filemon S Dela Cruz; Sarah Tannenbaum-Dvir; Julia L Glade-Bender; Andrew L Kung; Steven G DuBois; Harry P Kozakewich; Katherine A Janeway; Antonio R Perez-Atayde; Marian H Harris
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

5.  CT and MRI Findings of Soft Tissue Adult Fibrosarcoma in Extremities.

Authors:  Hexiang Wang; Pei Nie; Cheng Dong; Jie Li; Yonghua Huang; Dapeng Hao; Wenjian Xu
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.